TCE

Independent Bank Group, Inc. Reports Third Quarter Financial Results and Declares Quarterly Dividend

Retrieved on: 
月曜日, 10月 23, 2023
Banking, Professional Services, Finance, Sale, Capital, TCE, Federal funds, PPP, Bank statement, Growth, FHLB, Economic development, Lloyds Banking Group, Cryptocurrency, Bank, Video game, Real estate, Rare-earth element, FDIC, Fed

Net interest income was $109.0 million for third quarter 2023 compared to $147.3 million for third quarter 2022 and $113.6 million for second quarter 2023.

Key Points: 
  • Net interest income was $109.0 million for third quarter 2023 compared to $147.3 million for third quarter 2022 and $113.6 million for second quarter 2023.
  • The yield on interest-earning assets was 5.31% for third quarter 2023 compared to 4.30% for third quarter 2022 and 5.14% for second quarter 2023.
  • The net interest margin was 2.60% for third quarter 2023 compared to 3.64% for third quarter 2022 and 2.71% for second quarter 2023.
  • Total noninterest expense decreased $10.4 million compared to third quarter 2022 and $4.4 million compared to second quarter 2023.

Hancock Whitney Reports Third Quarter 2023 EPS of $1.12

Retrieved on: 
火曜日, 10月 17, 2023
Small Business, Banking, Professional Services, Finance, ATM, Central Time, TCE, Common, ORE, HWC, FHLB, EPS, FAS, SBIC, DDA, Insurance, LQA, Share repurchase, NIM, Total, Trust, Growth, ACL, Q&A, Pharmaceutical industry, Bank, Real estate, Rare-earth element, Beauty salon, Payment card

Net income for the third quarter of 2023 totaled $97.7 million, or $1.12 per diluted common share (EPS), compared to $117.8 million, or $1.35 per diluted common share, in the second quarter of 2023.

Key Points: 
  • Net income for the third quarter of 2023 totaled $97.7 million, or $1.12 per diluted common share (EPS), compared to $117.8 million, or $1.35 per diluted common share, in the second quarter of 2023.
  • Average earning assets were $33.1 billion for the third quarter of 2023, down $482.3 million, or 1%, from the second quarter of 2023.
  • Noninterest income totaled $86.0 million for the third quarter of 2023, up $2.8 million, or 3%, from the second quarter of 2023.
  • Net occupancy and equipment expense totaled $18.2 million in the third quarter of 2023, up $0.5 million, or 3%, from the second quarter of 2023.

iBio to Highlight Technology for Advancing Discovery of Bispecifics at Festival of Biologics

Retrieved on: 
火曜日, 10月 10, 2023
Platform, TCE, RMIT Platform Technologies Research Institute, Therapy, Toxicity, Trichloroethylene, HIV vaccine development, Cancer, Festival, Safety, SAN, CET, Machine learning, Research, Vaccine

BRYAN, Texas and SAN DIEGO, Oct. 10, 2023 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), an AI-driven innovator of precision antibody immunotherapies, announced today that Matt Greving Ph.D., its Vice President of Platform Technologies and Machine Learning, has been selected to present on the Company's technology for enhancing bispecific T-cell engagers (“TCE”) at the Festival of Biologics from Oct. 10-12 in Basel, Switzerland.

Key Points: 
  • The Festival of Biologics is one of the industry's most prominent conferences focused on biologics and the discovery and development of antibody-based therapeutics, bringing together leaders from pharma, biotech, and academic and research institutions.
  • He will present data demonstrating how iBio's machine learning (ML)-driven epitope steering and mammalian-display antibody libraries efficiently discover diverse TCE arms tuned for potency, toxicity, developability and cyno cross-reactivity.
  • The presentation will take place on Oct. 12 at 12:20 p.m. CET.
  • "We've demonstrated our technology can efficiently optimize next-gen CD3-T cell engager bispecifics, and we believe we are well positioned to use our platform to tackle hard-to-drug targets both internally and with partners and collaborators."

The Culinary Edge Teams Up with McCain Foods USA on New Vegetable Appetizer Line

Retrieved on: 
火曜日, 10月 10, 2023
Food, Partnership, Health, Eating, TCE, Flexitarianism, RBZ, Environment, SAN, FABI, Research, Restaurant

SAN FRANCISCO, Oct. 10, 2023 /PRNewswire/ -- The Culinary Edge (TCE), America's leading food and beverage innovation consultancy, announced today its partnership with McCain Foods USA, a national supplier of frozen potato and snack food products, on the creation of a new vegetable appetizer line. In response to changing consumer preferences, particularly among health-conscious flexitarians, the two companies came together and introduced V'DGZ, a line of plant and vegetable shareables that bring a playful crispy take to menu favorites.

Key Points: 
  • SAN FRANCISCO, Oct. 10, 2023 /PRNewswire/ -- The Culinary Edge (TCE), America's leading food and beverage innovation consultancy, announced today its partnership with McCain Foods USA, a national supplier of frozen potato and snack food products, on the creation of a new vegetable appetizer line.
  • These concepts underwent rigorous evaluation to ensure they would meet the demands of consumers, operators and manufacturing standards.
  • Our teams were able to leverage this demand for 'meat replacers' and create a variety of delicious vegetable-forward alternatives that diners and foodservice operators can enjoy," said Graham Humphreys, CEO, The Culinary Edge.
  • The Culinary Edge partners with the best and brightest food and beverage concepts from start to finish.

Claudin 18.2-Targeted Immunotherapy Research Report 2023: Landscape Analysis of Stakeholders, Drug Modalities, Pipeline and Business Opportunities from An Industry Perspective - ResearchAndMarkets.com

Retrieved on: 
水曜日, 9月 27, 2023
Health, Pharmaceutical, Incidence, Partnership, ADCC, Bi-specific T-cell engager, TCE, Hook effect, Overalls, Survival, Big Pharma, Business, Research, Appetite, History, Immunotherapy, Zolbetuximab, CDC, Vomiting, CAR, Science, Patient, Corporation, Antibody, Cancer, European, ADCP, Spacecraft, BDL, R, Stomach, GLOW, III, Bispecific monoclonal antibody, Safety, Sales, Vaccine, Pharmaceutical industry, Fine chemical, Risk management, Medical imaging, Dietary supplement

The "Claudin 18.2-Targeted Immunotherapy: A Landscape Analysis of Stakeholders, Drug Modalities, Pipeline and Business Opportunities from An Industry Perspective" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Claudin 18.2-Targeted Immunotherapy: A Landscape Analysis of Stakeholders, Drug Modalities, Pipeline and Business Opportunities from An Industry Perspective" report has been added to ResearchAndMarkets.com's offering.
  • This comprehensive report offers valuable insights into the world of claudin 18.2 (CLDN18.2)-targeted antibody and cell therapy candidates, as of August 2023.
  • You'll delve into the industry landscape surrounding innovative claudin18.2-targeted antibody and cell therapy candidates.
  • The report shines a light on 48 companies actively engaged in research and development within this field, highlighting 68 unique product candidates.

Pyxis Tankers Announces Closing of Ultramax JV Investment & Company Update

Retrieved on: 
月曜日, 9月 18, 2023
TCE, PXS, Frisbee, Acquisition, Hand, Cryptocurrency

The Company invested approximately $6.8 million in cash for a 60% ownership interest in the joint venture.

Key Points: 
  • The Company invested approximately $6.8 million in cash for a 60% ownership interest in the joint venture.
  • It is expected that the scrubber-fitted, eco-efficient vessel, which has been re-named the “Konkar Ormi”, will be initially chartered in the spot market.
  • In addition, Valentios Valentis, our Chairman and CEO, provided the following brief update:
    “The product tanker chartering environment continues to be constructive.
  • After funding our joint venture investment, the Company had approximately $31.9 million in total cash.

Moody's affirmed Ba3 rating and stable outlook for SeABank

Retrieved on: 
金曜日, 9月 15, 2023
Moody's Investors Service, Strategic Cooperation Agreement, SSB, TCE, Orient Commercial Joint Stock Bank, Payment Guaranteed, Seabank Power Station, Tangible common equity, BCA, Customer, Supply chain finance, Issuer, Supply, B1, Postcodes in the United Kingdom, FMCG, SCF, Security (finance), Bank

Moody's has affirmed SeABank's rating at Ba3 and stable outlook.

Key Points: 
  • Moody's has affirmed SeABank's rating at Ba3 and stable outlook.
  • The affirmation of SeABank's ratings with a stable outlook reflects Moody's expectation that the bank's strong and improving capitalization.
  • According to Moody's, SeABank continues to receive a Ba3 credit rating for both Issuer and Foreign Currency Deposit ratings.
  • Moody's affirmation of SeABank's rating with a stable outlook reflects the organization's expectations of the bank's strong and improving capital.

Moody's affirmed Ba3 rating and stable outlook for SeABank

Retrieved on: 
金曜日, 9月 15, 2023
Moody's Investors Service, Strategic Cooperation Agreement, SSB, TCE, Multimedia, Orient Commercial Joint Stock Bank, Payment Guaranteed, Seabank Power Station, Tangible common equity, BCA, Customer, Supply chain finance, Issuer, Supply, B1, Postcodes in the United Kingdom, FMCG, SCF, Security (finance), Bank

Moody's has affirmed SeABank's rating at Ba3 and stable outlook.

Key Points: 
  • Moody's has affirmed SeABank's rating at Ba3 and stable outlook.
  • The affirmation of SeABank's ratings with a stable outlook reflects Moody's expectation that the bank's strong and improving capitalization.
  • According to Moody's, SeABank continues to receive a Ba3 credit rating for both Issuer and Foreign Currency Deposit ratings.
  • Moody's affirmation of SeABank's rating with a stable outlook reflects the organization's expectations of the bank's strong and improving capital.

VANTAGE® TO FEATURE NOSE TO TAIL SURFACE TREATMENT SOLUTIONS AT MRO EUROPE

Retrieved on: 
木曜日, 9月 14, 2023
Aircraft, Plastic, Elastomer, Exhibition, HT, TCE, RAI Amsterdam Convention Centre, Booth, RAI Amsterdam, Professional baseball, Solvent, Corrosion, Trichloroethylene, PERC, Aviation Performance Solutions, PH, Tetrachloroethylene, Alloy, Arms industry, Adhesive, Vantage

DEERFIELD, Ill., Sept. 14, 2023 /PRNewswire/ -- Vantage, a leading manufacturer and global supplier of formulated cleaning products and surface treatments for the aerospace and defense market, will present new products at MRO Europe (Booth 1119) in Amsterdam, Netherlands on October 18 – 19, 2023.

Key Points: 
  • Vantage will present its complete range of aerospace chemical solutions at MRO Europe in Amsterdam, Netherlands October 18 – 19, 2023.
  • Company representatives from the Surface Treatment Technologies business will be available at Booth 1119 at the RAI Amsterdam.
  • Vantage presents aerospace chemical solutions at MRO Europe in Amsterdam, Netherlands on October 18 – 19, Booth 1119.
  • "We look forward to continuing our outreach within Europe, through our exhibition at the MRO Europe show in Amsterdam," says Jan Tinge, Executive Vice President, Performance Solutions.

Ten Ltd. Reports Profits for the Second Quarter and Six Months Ended June 30, 2023 and Declares Total Annual Dividend of $1.00 Per Common Share for 2023

Retrieved on: 
木曜日, 9月 7, 2023
Interest, TCE, DP2, Sale, LNG, EBITDA, Acquisition, Depreciation, TNP, TEN, Transport, VLCC, NYSE, Rare-earth element, Shipbuilding, Clothing, Video game, Security (finance), Holding company

Adjusted Earnings Before Interest Tax Depreciation & Amortization (EBITDA) more than doubled to $275.2 million from $133.3 million in the 2022 first six months, a 107% increase.

Key Points: 
  • Adjusted Earnings Before Interest Tax Depreciation & Amortization (EBITDA) more than doubled to $275.2 million from $133.3 million in the 2022 first six months, a 107% increase.
  • Adjusted EBITDA for the second quarter of 2023 recorded a 32% increase from the 2022 equivalent period and settled at $120.2 million.
  • Fleet utilization, despite a number of scheduled dry-dockings, remained high at 94.2% compared to 93.6% in the second quarter of 2022.
  • Payment for the special dividend is scheduled for October 26, 2023, to shareholders of record on October 20, 2023.